Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson (NYSE: JNJ ) will release its second quarter earnings report before the opening bell on Wednesday, July 15.

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings of $2.85 per share, up from $2.77 per share in the year-ago period.

The consensus estimate for Johnson & Johnson’s quarterly revenue is $25.05 billion.

It reported $23.74 billion last year, according to Pro.

On June 26, Johnson & Johnson announced additional data on IMAAVY throughout 12 abstracts at European Academy of Neurology 2026 Congress.

Johnson & Johnson shares rose 3.6% to close at $263.04 on Thursday. readers can access the latest analyst ratings on the Analyst Stock Ratings page.

Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how most-accurate analysts have rated the company in the recent period.

Guggenheim analyst Vamil Divan maintained a Buy rating and raised the price target from $266 to $270 on June 26, 2026.

This analyst has an accuracy rate of 78%.

Leerink Partners analyst David Risinger upgraded the stock from Market Perform to Outperform with a price target of $265 on May 13, 2026.

This analyst has an accuracy rate of 73%.

Barclays analyst Matt Miksic maintained the stock with an Equal-Weight rating and raised the price target from $234 to $255 on April 15, 2026.

This analyst has an accuracy rate of 62%.

Stifel analyst Rick Wise maintained the stock with a Hold rating and raised the price target from $220 to $250 on April 15, 2026.

This analyst has an accuracy rate of 68%.

Wells Fargo analyst Larry Biegelsen maintained the stock with an Overweight rating and raised the price target from $240 to $263 on April 15, 2026.

This analyst has an accuracy rate of 63%.

Considering buying JNJ stock? Here’s what analysts think: Photo via Shutterstock